KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Acquisitions (2017 - 2023)

Historic Acquisitions for Exact Sciences (EXAS) over the last 6 years, with Q4 2023 value amounting to $2.4 million.

  • Exact Sciences' Acquisitions fell 8430.16% to $2.4 million in Q4 2023 from the same period last year, while for Dec 2024 it was $67.8 million, marking a year-over-year increase of 206.28%. This contributed to the annual value of $52.4 million for FY2023, which is 25689.09% up from last year.
  • Latest data reveals that Exact Sciences reported Acquisitions of $2.4 million as of Q4 2023, which was down 8430.16% from $50.0 million recorded in Q3 2023.
  • Over the past 5 years, Exact Sciences' Acquisitions peaked at $973.9 million during Q4 2019, and registered a low of -$1.4 million during Q3 2022.
  • For the 5-year period, Exact Sciences' Acquisitions averaged around $128.9 million, with its median value being $11.1 million (2020).
  • Per our database at Business Quant, Exact Sciences' Acquisitions surged by 4735555.56% in 2021 and then crashed by 9905.26% in 2022.
  • Exact Sciences' Acquisitions (Quarter) stood at $973.9 million in 2019, then crashed by 100.0% to $4000.0 in 2020, then soared by 2104425.0% to $84.2 million in 2021, then crashed by 81.74% to $15.4 million in 2022, then plummeted by 84.3% to $2.4 million in 2023.
  • Its last three reported values are $2.4 million in Q4 2023, $50.0 million for Q3 2023, and $15.4 million during Q4 2022.